Skip to content

Target Heart Rate and Aerobic Interval Training

Exercise Intensity and Target Heart Rate During Aerobic Interval Training in Cardiac Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01550081
Enrollment
10
Registered
2012-03-09
Start date
2012-03-31
Completion date
2013-06-30
Last updated
2013-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

exercise intensity, aerobic interval training, cardiac rehabilitation, group exercise

Brief summary

Aerobic interval training is shown to be superior in increasing oxygen uptake in both healthy and patients with coronary artery disease (CAD), compared to moderate continuous training. However, in cardiac rehabilitation exercise groups, exercise intensity is usually controlled with perceived exertion (Borg scale). The investigators will investigate degree of agreement between target heart rate and perceived exertion during interval training in cardiac rehabilitation.

Interventions

OTHERRate of perceived exertion

Exercise intensity controlled by Borg scale

Exercise intensity controlled by heart rate monitors

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* referred to cardiac rehabilitation * able to perform exercise treadmill test

Exclusion criteria

* unstable angina * severe arrhythmias * heart failure

Design outcomes

Primary

MeasureTime frameDescription
degree of agreement between target heart rate (THR) and perceived exertionup to 1 hourExercise intensity during one-hour exercise session monitored by Borg, subsequently one-hour exercise session monitored by heart rate monitor

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026